Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-respondersChristian Gytz Ammitzbøll, Anne Troldborg, Signe Risbøl Vils et al.|Lara D. Veeken|2022Cited by 16
Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patientsChristian Gytz Ammitzbøll, Anne Troldborg, Fruzsina Szabados et al.|Clinical and Experimental Rheumatology|2023Cited by 3